Macquarie Has Lowered Expectations for Surgery Partners (NASDAQ:SGRY) Stock Price

Surgery Partners (NASDAQ:SGRY) had its price target reduced by research analysts at Macquarie from $35.00 to $34.00 in a report released on Wednesday,Benzinga reports. The firm currently has an “outperform” rating on the stock. Macquarie’s target price indicates a potential upside of 37.26% from the stock’s previous close.

Several other brokerages have also recently commented on SGRY. Benchmark reiterated a “buy” rating and issued a $50.00 price target on shares of Surgery Partners in a research note on Monday, August 26th. StockNews.com downgraded Surgery Partners from a “hold” rating to a “sell” rating in a research report on Wednesday, August 7th. UBS Group started coverage on Surgery Partners in a report on Monday, October 14th. They set a “buy” rating and a $38.00 price target for the company. KeyCorp began coverage on Surgery Partners in a research note on Friday, October 11th. They issued a “sector weight” rating on the stock. Finally, Citigroup lowered their target price on Surgery Partners from $38.00 to $36.00 and set a “buy” rating for the company in a research report on Wednesday, August 7th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and six have given a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $40.71.

Surgery Partners Trading Down 2.9 %

Surgery Partners stock opened at $24.77 on Wednesday. Surgery Partners has a 1 year low of $22.25 and a 1 year high of $36.92. The firm’s 50 day moving average price is $30.88 and its 200-day moving average price is $28.47. The company has a current ratio of 1.80, a quick ratio of 1.69 and a debt-to-equity ratio of 0.99.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the company. ProShare Advisors LLC boosted its position in shares of Surgery Partners by 7.8% during the first quarter. ProShare Advisors LLC now owns 13,588 shares of the company’s stock valued at $405,000 after buying an additional 986 shares during the period. First Eagle Investment Management LLC boosted its holdings in Surgery Partners by 16.5% during the 1st quarter. First Eagle Investment Management LLC now owns 339,474 shares of the company’s stock valued at $10,127,000 after acquiring an additional 48,100 shares during the period. Vanguard Group Inc. grew its position in Surgery Partners by 0.8% in the 1st quarter. Vanguard Group Inc. now owns 7,479,009 shares of the company’s stock valued at $223,099,000 after acquiring an additional 61,400 shares during the last quarter. EntryPoint Capital LLC grew its position in Surgery Partners by 257.1% in the 1st quarter. EntryPoint Capital LLC now owns 6,399 shares of the company’s stock valued at $191,000 after acquiring an additional 4,607 shares during the last quarter. Finally, Magnetar Financial LLC increased its stake in Surgery Partners by 511.7% in the first quarter. Magnetar Financial LLC now owns 165,466 shares of the company’s stock worth $4,936,000 after purchasing an additional 138,415 shares during the period.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.